582 CARDIOVASCULAR SAFETY OF DEGARELIX: RESULTS FROM A 12-MONTH, COMPARATIVE, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP PHASE III TRIAL IN PROSTATE CANCER PATIENTS

✍ Scribed by Klotz, Laurence; Smith, Matthew; Persson, Bo-Eric; Olesen, Tine Kold; Wilde, Arthur

• Book ID: 123045702
• Publisher: Lippincott Williams and Wilkins
• Year: 2010
• Tongue: English
• Weight: 45 KB
• Volume: 183
• Category: Article
• ISSN: 0022-5347
• DOI: 10.1016/j.juro.2010.02.841